News & Media

Panlabs Advances Its Capabilities in Biologics! Acquiring Core Recombinant Protein Expression System Technologies

Published on 2025.06.24 ・ Company news

Panlabs Advances Its Capabilities in Biologics! Acquiring Core Recombinant Protein Expression System Technologies

Panlabs Advances Its Capabilities in Biologics! ✨

In 2025, Panlabs successfully completed a technology transfer with the Agricultural Technology Research Institute, acquiring core recombinant protein expression system technologies.

This collaboration not only strengthens Panlabs’ technical foundation in the large-molecule (biologics) domain, but also injects new momentum into the localization and value enhancement of Taiwan’s biotechnology industry.

 

Panlabs Advances Its Capabilities in Biologics! Acquiring Core Recombinant Protein Expression System Technologies

Panlabs has now established comprehensive recombinant protein production capabilities, including:

🧬 Cytokines
🌱 Growth Factors
🔬 Structural Proteins
🧪 Industrial Enzymes

Driven by innovation, we will continue to expand into diverse applications and unlock new opportunities in the evolving biotech landscape.

Panlabs Advances Its Capabilities in Biologics! Acquiring Core Recombinant Protein Expression System Technologies
Panlabs Advances Its Capabilities in Biologics! Acquiring Core Recombinant Protein Expression System Technologies
關閉

建議您使用以下瀏覽器觀看本網站,
以獲得最佳瀏覽效果。

要下載瀏覽器,請直接點擊以下: